AAM submitted comments to CMS, highlighting the extent and ways in which Part D sponsors and their PBMs engage in practices that favor, intentionally or unintentionally, more expensive reference drugs and biological products over generics.
Building on the success during the COVID-19 pandemic, independent community pharmacies are taking steps to enhance their readiness for future public health emergencies.
CARE Pharmacies appointed Ryan Hollingsworth, Natalie Ryan and Steven Pieri to its 2025 board of directors, and Lionel Phillips will serve as vice chairman on its executive committee.